title: Meningitis in tropics--what is the optimal initial therapy?
abstract: Risk factors, etiology, epidemiology and initial therapy of community acquired meningitis in tropics is briefly reviewed.
authors.forename: J
authors.initials: J
authors.lastname: Benca
authors.forename: L Seng
authors.initials: LS
authors.lastname: Duong
authors.forename: A
authors.initials: A
authors.lastname: Shahum
authors.forename: A
authors.initials: A
authors.lastname: Ondrus
authors.forename: A
authors.initials: A
authors.lastname: Koleno
authors.forename: M
authors.initials: M
authors.lastname: Bartkovjak
authors.forename: V
authors.initials: V
authors.lastname: Sladecko
authors.forename: J Mutuku
authors.initials: JM
authors.lastname: Muli
mesh_terms: D017954:Africa South of the Sahara; D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000145:classification / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D017714:Community-Acquired Infections / Q000628:therapy; D005062:European Union; D006801:Humans; D007231:Infant, Newborn; D016920:Meningitis, Bacterial / Q000628:therapy*; D009656:North America; D013020:South America; D016896:Treatment Outcome; D014329:Tropical Climate; D014330:Tropical Medicine
chemical_list: D000890:Anti-Infective Agents